457 related articles for article (PubMed ID: 32103345)
41. Calcitonin gene-related peptide (CGRP) is a key molecule released in acute migraine attacks-Successful translation of basic science to clinical practice.
Edvinsson L
J Intern Med; 2022 Oct; 292(4):575-586. PubMed ID: 35532284
[TBL] [Abstract][Full Text] [Related]
42. Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
Yuan H; Spare NM; Silberstein SD
Headache; 2019 Jul; 59 Suppl 2():20-32. PubMed ID: 31291020
[TBL] [Abstract][Full Text] [Related]
43. Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine.
Zhang Q; Han X; Wu H; Zhang M; Hu G; Dong Z; Yu S
Mol Pain; 2019; 15():1744806918820452. PubMed ID: 30799680
[TBL] [Abstract][Full Text] [Related]
44. A Review of the Potential Receptors of Migraine with a Special Emphasis on CGRP to Develop an Ideal Antimigraine Drug.
Naduchamy KP; Parthasarathy V
Curr Mol Pharmacol; 2021; 14(1):11-26. PubMed ID: 32838728
[TBL] [Abstract][Full Text] [Related]
45. Beyond CGRP: The calcitonin peptide family as targets for migraine and pain.
Rees TA; Hendrikse ER; Hay DL; Walker CS
Br J Pharmacol; 2022 Feb; 179(3):381-399. PubMed ID: 34187083
[TBL] [Abstract][Full Text] [Related]
46. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat.
Storer RJ; Akerman S; Goadsby PJ
Br J Pharmacol; 2004 Aug; 142(7):1171-81. PubMed ID: 15237097
[TBL] [Abstract][Full Text] [Related]
47. Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons.
Pozo-Rosich P; Storer RJ; Charbit AR; Goadsby PJ
Cephalalgia; 2015 Dec; 35(14):1298-307. PubMed ID: 25792688
[TBL] [Abstract][Full Text] [Related]
48. Migraine headache pathophysiology.
Andreou AP; Pereira AD
Handb Clin Neurol; 2023; 198():61-69. PubMed ID: 38043971
[TBL] [Abstract][Full Text] [Related]
49. CGRP-receptor antagonism in migraine treatment.
Edvinsson L; Petersen KA
CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):240-6. PubMed ID: 17691979
[TBL] [Abstract][Full Text] [Related]
50. Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia.
Raddant AC; Russo AF
Headache; 2014 Mar; 54(3):472-84. PubMed ID: 24512072
[TBL] [Abstract][Full Text] [Related]
51. Neurokinins and their receptors in the rat trigeminal system: Differential localization and release with implications for migraine pain.
Edvinsson JC; Reducha PV; Sheykhzade M; Warfvinge K; Haanes KA; Edvinsson L
Mol Pain; 2021; 17():17448069211059400. PubMed ID: 34898306
[TBL] [Abstract][Full Text] [Related]
52. Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system.
Labastida-Ramírez A; Rubio-Beltrán E; Haanes KA; Chan KY; Garrelds IM; Johnson KW; Danser AHJ; Villalón CM; MaassenVanDenBrink A
Pain; 2020 May; 161(5):1092-1099. PubMed ID: 31977930
[TBL] [Abstract][Full Text] [Related]
53. Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.
Eftekhari S; Edvinsson L
Ther Adv Neurol Disord; 2010 Nov; 3(6):369-78. PubMed ID: 21179597
[TBL] [Abstract][Full Text] [Related]
54. Role of CGRP in Migraine.
Edvinsson L
Handb Exp Pharmacol; 2019; 255():121-130. PubMed ID: 30725283
[TBL] [Abstract][Full Text] [Related]
55. Calcitonin gene-related peptide (CGRP): a new target for migraine.
Russo AF
Annu Rev Pharmacol Toxicol; 2015; 55():533-52. PubMed ID: 25340934
[TBL] [Abstract][Full Text] [Related]
56. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
[TBL] [Abstract][Full Text] [Related]
57. Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets.
Haanes KA; Edvinsson L
CNS Drugs; 2019 Jun; 33(6):525-537. PubMed ID: 30989485
[TBL] [Abstract][Full Text] [Related]
58. Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists.
Edvinsson L
Expert Opin Ther Targets; 2007 Sep; 11(9):1179-88. PubMed ID: 17845144
[TBL] [Abstract][Full Text] [Related]
59. Anti-CGRP in cluster headache therapy.
Giani L; Proietti Cecchini A; Leone M
Neurol Sci; 2019 May; 40(Suppl 1):129-135. PubMed ID: 30820761
[TBL] [Abstract][Full Text] [Related]
60. Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons.
Buldyrev I; Tanner NM; Hsieh HY; Dodd EG; Nguyen LT; Balkowiec A
J Neurochem; 2006 Dec; 99(5):1338-50. PubMed ID: 17064360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
